Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Shandong Xinhua Pharmaceutical Company Limited Class H ( (HK:0719) ) just unveiled an announcement.
Shandong Xinhua Pharmaceutical Company Limited has announced its upcoming Annual General Meeting (AGM) scheduled for June 13, 2025, in Zibo City, China. The AGM will address several key resolutions, including the approval of the 2024 annual report, financial statements, and profit distribution plan. Additionally, the meeting will consider the re-appointment of auditors and amendments to the company’s business scope and Articles of Association. These resolutions are crucial for the company’s strategic direction and compliance with regulatory requirements, impacting its operational and governance framework.
More about Shandong Xinhua Pharmaceutical Company Limited Class H
Shandong Xinhua Pharmaceutical Company Limited is a company operating in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical products. The company is based in Zibo City, Shandong Province, China, and is involved in the development and sale of various pharmaceutical products.
Average Trading Volume: 2,118,963
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$8.56B
Find detailed analytics on 0719 stock on TipRanks’ Stock Analysis page.